Enrique González Gallardo

Dr. Enrique González Gallardo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2023 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
ASAlejandro N. Santos
Alejandro N. Santos
LRLaurèl Rauschenbach
Laurèl Rauschenbach
CRChristoph Riess
Christoph Riess
IGIason Georgiades
Iason Georgiades
BFBerrin Fiçilar
Berrin Fiçilar
PDPhilipp Dammann
Philipp Dammann

22 April 2025 in Global Spine Journal
Verified
Journal Article
Open access
Enrique González GallardoEnrique González Gallardo
Enrique González Gallardo
JEJustyna O. Ekert
Justyna O. Ekert
HIHarshvardhan Iyer
Harshvardhan Iyer
JLJuan Pablo Navarro-García de Llano
Juan Pablo Navarro-García de Llano
JSJesús E. Sánchez-Garavito
Jesús E. Sánchez-Garavito
RNRodrigo Navarro-Ramírez
Rodrigo Navarro-Ramírez
Study Design: Systematic Review. Objective: To assess the current literature regarding the accuracy of different imaging modalities and criteria used to assess lumbar fusion, and their correlation with surgical direct observation as the current Gold Standard. Methods: Following PRISMA guidelines, we conducted a comprehensive search of PubMed, Embase, Google Scholar, and Cochrane Library, studies were included if they focused on patients with a prior history of lumbar interbody fusion and at least 1 year of radiographic follow-up. The review assessed the sensitivity, specificity, and accuracy of different imaging techniques, and their correlation with surgical findings. Results: Thirteen studies (1989-2019) were reviewed, including 715 patients, common imaging modalities included plain radiographs (53.8%), Computed Tomography (CT) (69.2%), and dynamic radiographs (30.7%). CT appeared as the most utilized modality post-2006. There was substantial variability in diagnostic accuracy, with CT showing high variability in sensitivity and specificity. Descriptive criteria for fusion were widely used, but interobserver agreement was generally low. Conclusion: The review highlights a lack of standardized criteria for assessing lumbar fusion. Despite advancements in imaging techniques, the variability in diagnostic parameters suggests a need for consensus and multicentric studies to stablish reliable, universal criteria for evaluating fusion success.

7 March 2023 in World Neurosurgery
Verified
Journal Article
Closed access
Enrique González GallardoEnrique González Gallardo
Enrique González Gallardo
LRLaurèl Rauschenbach
Laurèl Rauschenbach
ASAlejandro N. Santos
Alejandro N. Santos
CRChristoph Riess
Christoph Riess
YLYan Li
Yan Li
PDPhilipp Dammann
Philipp Dammann

2 July 2025 in World Neurosurgery
Verified
Journal Article
Open access
HGHanah Gull
Hanah Gull
ASAlejandro N. Santos
Alejandro N. Santos
LRLaurèl Rauschenbach
Laurèl Rauschenbach
Enrique González GallardoEnrique González Gallardo
Enrique González Gallardo
AMAnna Michel
Anna Michel
PDPhilipp Dammann
Philipp Dammann
The goal of this study was to analyze retrospectively the course of patients with cerebral cavernous malformation (CCM) and associated developmental venous anomaly (DVA) concerning neurological outcome and formation of CCM recurrence or de-novo formation after surgical removal of the lesion. 1469 patients diagnosed with CCM were referred to our institution from 2003 to 2022. Adult patients with sporadic CCM, complete magnetic resonance imaging dataset, and ≥2 follow-up (FU) investigations after surgical resection were analyzed. Patient's clinical data, surgical, and radiological reports were retrospectively assessed. Multiple factors regarding functional outcome were scanned using logistic regression analyses with P < 0.05. Preoperative and postoperative neurological function was assessed using the modified Rankin Scale (mRS). 183 patients were included in this study; 59 of 183 presented associated DVA. Mean preoperative mRS in the CCM + DVA group was 1.7 (±0.9), and in the CCM-DVA group was 1.97 (±0.8), while mean mRS at the last FU was 0.65 (±0.89) in the CCM + DVA group and 0.93 (±0.92) in the CCM-DVA group. Recurrence of CCM lesion was seen in 1 case in the CCM + DVA group and in 2 cases in the CCM-DVA group. Significant differences in the neurological status preoperatively (P = 0.046) and at the last FU (P = 0.049) could be detected for the benefit of the CCM + DVA group. DVA does not represent an additional risk for neurological deterioration in the surgical resection of CCM. Postoperative CCM recurrence is negligible.

Verified
Journal Article
Open access
PDF file
HGHanah Gull
Hanah Gull
Enrique González GallardoEnrique González Gallardo
Enrique González Gallardo
LRLaurèl Rauschenbach
Laurèl Rauschenbach
TDThiemo Florin Dinger
Thiemo Florin Dinger
DZDenise Zwanziger
Denise Zwanziger
PDPhilipp Dammann
Philipp Dammann
Cerebral Cavernous Malformations (CCMs) are low-flow vascular lesions located within the central nervous system, with a reported prevalence in the general population of 0.16–0.5%. Patients with CCMs may remain asymptomatic or present new onset symptoms such as seizures or focal neurological deficits often related to the occurrence of intracerebral hemorrhage. CCM may appear sporadic or as part of familial forms linked to mutations in the CCM-gene cluster, affecting endothelial cell integrity and triggering molecular cascades, including the MEKK3/KLF2/4 signaling pathway. Recent studies have highlighted the roles of inflammatory, angiogenic, and coagulation pathways alongside the emerging evidence of a gut–brain axis influencing microbiome-driven TLR4 signaling. This systematic review aims to describe molecular biomarkers associated with CCM pathophysiology, emphasizing their potential use as diagnostic and prognostic tools. Circulating plasma biomarkers such as CRP, vitamin D, and interleukins may reflect ongoing inflammatory and endothelial processes, while some imaging biomarkers like Quantitative Susceptibility Mapping (QSM) have shown a correlation with iron deposition and vascular leakage. Leveraging both circulating and imaging biomarkers may improve the therapeutic decision-making process. Further studies are encouraged to validate these findings and to facilitate the development of personalized, evidence-based strategies for the management of CCM.